Lenalidomide, Dexamethasone, and Elotuzumab With or Without Cyclophosphamide in Treating Patients With Relapsed Primary Amyloidosis
Clinical trial NCT03252600 · UNKNOWN
Trial details
- NCT number
- NCT03252600
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-25
- Primary completion
- 2023-12-07
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.